Unitedhealth Group
Clinical Pharmacist, Medicare Part D Formulary Development
Department of Veterans Affairs Dec 2013 - Mar 2017
Inpatient Intern Pharmacist
Bayer Healthcare Jun 2013 - Aug 2013
Manufacturing Sciences Purification Intern
University of Southern California Aug 2011 - May 2013
Undergraduate Research Assistant
University of Southern California Jan 2013 - May 2013
Pharmacy Clerk
Education:
University of California, San Francisco 2013 - 2017
Doctorates, Doctor of Pharmacy, Pharmacy
University of Southern California 2009 - 2013
Bachelors, Bachelor of Science, Biochemistry
Punahou School 2005 - 2009
Ucsf School of Pharmacy
University of California
University of California, Riverside
Student
Daiso Usa
Sales Associate
Education:
University of California, Riverside 2018 - 2022
Bachelors, International Affairs, Political Science
University of California, Riverside 2011 - 2015
Bachelors
Skills:
Customer Service Microsoft Word Retail Social Media Time Management
But the challenge trial Hopkins took part in did go forward. We started with the lowest dose we can reliably produce, said Christopher Chiu, a researcher at Imperial College London, who headed the experiment. If nobody got infected theyd step up the dose, slightly, he said, but on the first try,
Date: May 09, 2022
Category: More news
Source: Google
First human challenge trial shows how COVID-19 strikes
do that, because normally, patients only come to your attention if they have developed symptoms, and so you miss all of those preceding days when the infection is brewing," lead study author Dr. Christopher Chiu, an infectious disease physician and immunologist at Imperial College London, told CNN.
Date: Apr 01, 2022
Category: Health
Source: Google
Covid-19 news: Hong Kong restricts public gatherings as omicron surges
the study support the use of lateral flow tests in picking up infectious cases of the disease. We found that overall, lateral flow tests correlate very well with the presence of infectious virus, Christopher Chiu at Imperial College London, the trials chief investigator, said in a statement. Even
Date: Feb 08, 2022
Category: More news
Source: Google
First COVID-19 human challenge study yields infection clues
Christopher Chiu, MD, PhD, an infectious disease specialist at Imperial College London and the trial's chief investigator, said in an Imperial College London press release, "Even though in the first day or two they may be less sensitive, if you use them correctly and repeatedly, and act on them if t
Date: Feb 02, 2022
Category: More news
Source: Google
To aid vaccine research, U.K. approves deliberate infections of volunteers with coronavirus
People who become infected will quickly be offered remdesivir, a drug approved in several countries to treat infected people who are at high risk of severe COVID-19 or who are already hospitalized with the disease, says the trials principal investigator, immunologist Christopher Chiu of Imperial C
Date: Feb 17, 2021
Category: More news
Source: Google
Googleplus
Christopher Chiu
Work:
Punahou School
Education:
University of Southern California - Biochemistry, Punahou School